Cite
HARVARD Citation
Antill, Y. et al. (n.d.). LBA12Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601). Annals of oncology. p. . [Online].